The 2026 Surviving Sepsis Campaign guidelines: a turning point for emergency medicine.

Sepsis remains one of the most pressing challenges in emergency medicine. With approximately 49 million cases and 13 million deaths each year worldwide, it constitutes a global health emergency of the first order [1]. In Europe alone, an estimated 3.4 million individuals are affected annually, with in-hospital mortality hovering around 24%. More than 80% of patients with sepsis receive their initial assessment and treatment in the emergency department (ED) – making the ED not merely a gateway to care, but the frontline of the battle against sepsis. For emergency physicians, this reality has long translated into an intense and challenging pressure: act fast, act right, and do so often under conditions of diagnostic uncertainty, overcrowding, and constrained resources [2]. It is against this backdrop that successive iterations of the Surviving Sepsis Campaign (SSC) guidelines have been released, debated, and implemented – or not. A history of moving targets The SSC guidelines have never been static [3]. Since their inception in 2004, they have undergone multiple revisions – in 2008, 2012, 2016, and 2021 – each time incorporating new evidence, refining recommendations, and occasionally reversing previous positions. The controversy and removal of the early goal-directed therapy recommendation is one example of changing guidance. Likewise, sepsis bundles, developed to expedite translation of SSC guidelines into practice, have been updated, from 6 to 24-h treatment bundles in 2004, 3 and 6-h bundles in 2013, to the 1-h bundle in 2018. Each update of the guidelines and bundles has prompted debate, and each iteration revealed that the evidence base for sepsis management, while growing, remains a work in progress – as reflected in the predominance of conditional recommendations and low-certainty evidence throughout the guidelines. The emergency medicine community has been a vocal participant in these debates. The European Society for Emergency Medicine (EUSEM) notably issued a formal expression of concern regarding the 1-h bundle in 2019, highlighting feasibility challenges in real-world ED settings and raising concerns that rigid timeframes could disrupt workflows and paradoxically increase inappropriate broad-spectrum antibiotic use. These concerns were not objections rooted in disengagement – quite the contrary. They reflected a deep commitment to evidence-based, implementable, patient-centered care. In 2021, the SSC guidelines included new antibiotic and fluids resuscitation timing recommendations. 2026: a different kind of update The 2026 SSC guidelines represent something new [4]. For the first time, EUSEM has sponsored and endorsed the guidelines. This is not a minor administrative footnote – it marks a meaningful shift in the relationship between the intensive care and emergency medicine communities around sepsis. It reflects a document that took seriously the perspectives of those who manage patients in the early, uncertain, chaotic hours of sepsis onset. This shift is structural and not only symbolic. Several emergency physicians contributed directly to the guidelines development process, notably within the screening and early management subgroup – a domain that sits squarely at the heart of emergency practice. The recommendations that emerged from this group reflect a more nuanced approach: a renewed emphasis on validated early warning scores over quick sequential organ failure assessment (qSOFA) as standalone screening tools, a context-sensitive approach to antibiotic timing that differentiates septic shock from possible sepsis, and a new conditional recommendation for prehospital sepsis screening that acknowledges the reality of ambulance-based care. What is happening on the ground? Endorsement of guidelines is one thing, implementation is another. A timely survey published in this issue of EJEM by Bolanaki and colleagues [5] offers a sobering, real-world counterpoint to guideline aspirations. The ISG-ED European Survey, conducted among 402 EDs across 28 European countries, reveals the extent of the gap between what is recommended and what is actually practiced. The picture is mixed. A majority of EDs (73%) report having a sepsis protocol in place – encouraging, but less so when one notes that fewer than 50% have systematic monitoring measures, and nearly 30% conduct no sepsis-specific training at all. Just over 50% of respondents report completing all elements of the 1-h bundle within the specified timeframe. The most frequently cited barriers are high patient volumes, understaffing, and unclear sepsis definitions – the same obstacles emergency physicians have flagged for years. Strikingly, qSOFA – despite explicit recommendations against its use as a standalone screening tool in both the 2021 and 2026 SSC guidelines – remains the most commonly used screening instrument across European EDs. The survey also highlights a genuine and widespread concern about antimicrobial stewardship: nearly two-thirds of respondents believe the 1-h bundle increased broad-spectrum antibiotic use in their EDs. Whether this perception translates into measurable overprescribing is debated (however, emerging evidence suggests that timely treatment of sepsis is not associated with antibiotic overprescribing), but the concern itself shapes clinician behavior and guideline reception [6]. What the 2026 guidelines say – and mean – for emergency medicine For emergency physicians, the 2026 guidelines offer several clinically meaningful updates. The recommendation to use NEWS, NEWS2, MEWS, or SIRS over qSOFA as a standalone in-hospital screening tool is now stronger, backed by moderate-certainty evidence. The role of biomarkers in early sepsis management receives dedicated attention, from familiar tools such as lactate or procalcitonin to novel host-response biomarkers with emerging evidence [7,8]. The antibiotic timing framework is more explicitly stratified: immediate administration within 1 h for probable or definite septic shock, and within 3 h for possible sepsis without shock – a nuance that matters enormously in ED triage. A new recommendation supports prehospital antibiotic administration in patients with probable septic shock when the anticipated time to hospital evaluation exceeds 60 min [9,10]. On resuscitation, the 30 ml/kg initial fluid recommendation is maintained but with important caveats around patient-specific factors. Balanced crystalloids are now preferred over normal saline, and dynamic measures of fluid responsiveness are favored over static parameters [11]. Vasopressors can be initiated peripherally rather than awaiting central access – a practical point with direct implications for ED workflow [12]. A shared responsibility The 2026 SSC guidelines represent the most collaborative, geographically diverse, and methodologically rigorous iteration yet. Their endorsement by EUSEM is a statement that the emergency medicine community is not only willing but equipped to help shape the global sepsis agenda – which is not yet the case for most guidelines on acute conditions. The work that remains is implementation – in overcrowded EDs, with stretched teams, in systems where monitoring is not always feasible and training a challenge [13,14]. The survey by Bolanaki et al. reminds us how much ground there is still to cover. Guidelines matter. But they matter most when they reach the bedside. Acknowledgements Conflicts of interest R.L. is president of EUSEM. H.C.P. served as co-chair of the 2026 SSC Adult Guidelines and is a consultant to Aurobac Therapeutics. W.B. is the chair of the European Society for Emergency Medicine (EUSEM) guidelines committee. For the remaining authors, there are no conflicts of interest.